UPDATE : Thursday, October 17, 2019
상단여백
Foreign trainees satisfied with Lee Jong-wook Fellowship
The Lee Jong-wook Fellowship is receiving favorable feedback from trainees ...
by Choi Gwang-seok  |  2019-09-27 15:05
라인
Regulator explained why it banned stomach medicine ranitidine altogether
The Ministry of Food and Drug Safety Thursday offered a briefing to pharmac...
by Jeong Sae-im  |  2019-09-27 15:02
라인
Samsung Bioepis releases P3 results of Bevacizumab biosimilar in EU
Samsung Bioepis has presented the results of phase 3 study clinical evaluat...
by Lee Han-soo  |  2019-09-27 11:37
라인
Genexine sets up joint firm in Thailand
Genexine said that it has established KinGen Biotech in Thailand, a joint v...
by Lee Han-soo  |  2019-09-26 17:00
라인
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question
The recent failures by Korean biotech companies to reach meaningful results...
by Lee Han-soo  |  2019-09-26 15:39
라인
‘Samsung BioLogics destroyed evidence to hide accounting fraud for months’
Executives of Samsung BioLogics and affiliated companies claimed that they ...
by Jeong Sae-im  |  2019-09-26 15:24
라인
Celltrion to start marketing Herzuma in Middle East
Celltrion Healthcare said that it won the bid to sell Herzuma, an anticance...
by Lee Han-soo  |  2019-09-26 15:02
라인
Researchers discover spreading probability of wet macular degeneration
A study conducted by a local research team has revealed the transmission pr...
by Lee Han-soo  |  2019-09-26 14:23
라인
Ranitidine heartburn drugs banned due to carcinogen risk
The Ministry of Food and Drug Safety has suspended the manufacturing and se...
by Lee Hye-seon  |  2019-09-26 13:32
라인
Pfizer’s leukemia therapy Besponsa to get insurance benefit
The government said it would grant insurance benefit to Pfizer’s leukemia t...
by Kim Yun-mi  |  2019-09-26 11:26
라인
'Xtandi emerges as convenient treatment option for prostate cancer patients'
Astellas Korea is strengthening its position in the local prostate cancer m...
by Lee Han-soo  |  2019-09-25 17:39
라인
Korea, Uzbekistan speed up public health cooperation
Korea will accelerate cooperation with Uzbekistan in public health, initiat...
by Kwak Sung-sun  |  2019-09-25 15:26
라인
Ministry to announce results of ranitidine testing for carcinogen
The government is likely to announce the results of the test on ranitidine ...
by Lee Hye-seon  |  2019-09-25 14:46
라인
Helixmith blames hospital for absurd drug mix-up
Helixmith used to be one of the promising biotech firms with its market cap...
by Jeong Sae-im  |  2019-09-25 13:42
라인
NCC develops new chemotherapy to increase survival of osteosarcoma patients
A research team at the National Cancer Center has developed new chemotherap...
by Lee Han-soo  |  2019-09-25 11:48
라인
Court rejects Kolon’s appeal over Invossa license revocation
A Seoul court turned down Kolon Life Science’s appeal for stopping the gove...
by Jeong Sae-im  |  2019-09-25 11:18
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment
Huons said that it has signed an exclusive licensing agreement for developi...
by Lee Han-soo  |  2019-09-25 11:18
라인
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
AstraZeneca announced detailed results of the landmark phase 3 DAPA-HF tria...
by Lee Han-soo  |  2019-09-24 18:08
라인
Qurient enrolls patients for trials of atopy treatment
Qurient said Tuesday that it has completed patient enrollment for phase 2b ...
by Lee Han-soo  |  2019-09-24 17:00
라인
Hanmi’s US partner to unveil results of anticancer drug study
Hanmi Pharmaceutical said that Athenex, its U.S. partner, plans to present ...
by Lee Han-soo  |  2019-09-24 17:00
여백
여백
여백
Back to Top